4SC's Successful Development Continues in Third Quarter of 2012

News   Nov 09, 2012

 
4SC's Successful Development Continues in Third Quarter of 2012
 
 
 

RELATED ARTICLES

Researchers Develop Novel ‘One-pot’ Approach to Conjugated Tetraenes Synthesis

News

TUAT researchers have achieved the new synthetic route of conjugated tetraenes from inexpensive and easily available 1,3-butadiene and substituted acetylenes by a one-pot approach under mild conditions. Conjugated tetraenes are important key substructures in biologically active natural products such as vitamins, and anti-mycotic drugs.

READ MORE

Prostate Tumor Progression Dictated by Cancer’s Gene-determined “Immune Landscape”

News

The field of immunotherapy is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of patients, suggesting that as-yet unidentified variations among tumors result in distinct paths of disease progression and response to therapy.

READ MORE

3D Structure of DHHC Proteins Provides Blueprint for Drug Design

News

The first three-dimensional structure of DHHC proteins — enzymes involved in many cellular processes, including cancer — explains how they function and may offer a blueprint for designing therapeutic drugs.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE